Devi GR - Search Results

1

Prostate cancer: status of current treatments and emerging antisense-based therapies.

Devi GR. Devi GR. Curr Opin Mol Ther. 2002 Apr;4(2):138-48. Curr Opin Mol Ther. 2002. PMID: 12044035 Review.

2

c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.

Sekhon HS, London CA, Sekhon M, Iversen PL, Devi GR. Sekhon HS, et al. Among authors: devi gr. Lung Cancer. 2008 Jun;60(3):347-54. doi: 10.1016/j.lungcan.2007.10.028. Epub 2007 Dec 21. Lung Cancer. 2008. PMID: 18096271

3

Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.

Ko YJ, Devi GR, London CA, Kayas A, Reddy MT, Iversen PL, Bubley GJ, Balk SP. Ko YJ, et al. Among authors: devi gr. J Urol. 2004 Sep;172(3):1140-4. doi: 10.1097/01.ju.0000134698.87862.e6. J Urol. 2004. PMID: 15311058

4

X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells.

Amantana A, London CA, Iversen PL, Devi GR. Amantana A, et al. Among authors: devi gr. Mol Cancer Ther. 2004 Jun;3(6):699-707. Mol Cancer Ther. 2004. PMID: 15210856

5

XIAP as target for therapeutic apoptosis in prostate cancer.

Devi GR. Devi GR. Drug News Perspect. 2004 Mar;17(2):127-34. doi: 10.1358/dnp.2004.17.2.829046. Drug News Perspect. 2004. PMID: 15098067 Review.

6

A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.

London CA, Sekhon HS, Arora V, Stein DA, Iversen PL, Devi GR. London CA, et al. Among authors: devi gr. Cancer Gene Ther. 2003 Nov;10(11):823-32. doi: 10.1038/sj.cgt.7700642. Cancer Gene Ther. 2003. PMID: 14605668

7

Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.

Iversen PL, Arora V, Acker AJ, Mason DH, Devi GR. Iversen PL, et al. Among authors: devi gr. Clin Cancer Res. 2003 Jul;9(7):2510-9. Clin Cancer Res. 2003. PMID: 12855625 Clinical Trial.

8

Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model.

Knapp DC, Mata JE, Reddy MT, Devi GR, Iversen PL. Knapp DC, et al. Among authors: devi gr. Anticancer Drugs. 2003 Jan;14(1):39-47. doi: 10.1097/00001813-200301000-00006. Anticancer Drugs. 2003. PMID: 12544257

9

Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.

Devi GR, Oldenkamp JR, London CA, Iversen PL. Devi GR, et al. Prostate. 2002 Nov 1;53(3):200-10. doi: 10.1002/pros.10151. Prostate. 2002. PMID: 12386920

10

Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo.

Devi GR, Sprenger CC, Plymate SR, Rosenfeld RG. Devi GR, et al. Prostate. 2002 May 1;51(2):141-52. doi: 10.1002/pros.10068. Prostate. 2002. PMID: 11948969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results